<!DOCTYPE html><html lang="en-us" >


<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  
  
  
    <meta name="generator" content="Wowchemy 5.6.0 for Hugo" />
  

  
  












  
  










  







  
  

  
  
  

  
  
  
  
  
  

  

  
  
  
    
  
  <meta name="description" content="A highly-customizable Hugo documentation theme powered by Wowchemy website builder." />

  
  <link rel="alternate" hreflang="en-us" href="https://example.com/tag/cancers/" />

  
  
  
    <meta name="theme-color" content="#1565c0" />
  

  
  
    
    <script src="/js/mathjax-config.js"></script>
  

  

  <link rel="stylesheet" href="/css/vendor-bundle.min.c7b8d9abd591ba2253ea42747e3ac3f5.css" media="print" onload="this.media='all'">

  
  
  
    
    

    
    
    
    
      
      
    
    
    

    
    
    

    

    
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml.js" integrity="" crossorigin="anonymous" async></script>
      
    
      
      

      
      

      
    
      
      

      
      

      
    
  

  
  
  
  
  
  
  <link rel="stylesheet" href="/css/wowchemy.7579f2ea081d74b9cb40a7d984071feb.css" />

  
  
  
  
  
  
  
    
    
    <link rel="stylesheet" href="/css/libs/chroma/github-light.min.css" title="hl-light" media="print" onload="this.media='all'" >
    <link rel="stylesheet" href="/css/libs/chroma/dracula.min.css" title="hl-dark" media="print" onload="this.media='all'" disabled>
  

  
  



  


  


  




  
  
  

  
  
    <link rel="alternate" href="/tag/cancers/index.xml" type="application/rss+xml" title="BM Sci-Tech Memento" />
  

  
  
    <link rel="manifest" href="/manifest.webmanifest" />
  

  
  <link rel="icon" type="image/png" href="/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_32x32_fill_lanczos_center_3.png" />
  <link rel="apple-touch-icon" type="image/png" href="/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_180x180_fill_lanczos_center_3.png" />

  <link rel="canonical" href="https://example.com/tag/cancers/" />

  
  
  
  
  
  
  
  
    
    
  
  

  
  
    
    
  
  <meta property="twitter:card" content="summary" />
  
    <meta property="twitter:site" content="@wowchemy" />
    <meta property="twitter:creator" content="@wowchemy" />
  
  <meta property="og:site_name" content="BM Sci-Tech Memento" />
  <meta property="og:url" content="https://example.com/tag/cancers/" />
  <meta property="og:title" content="Cancers | BM Sci-Tech Memento" />
  <meta property="og:description" content="A highly-customizable Hugo documentation theme powered by Wowchemy website builder." /><meta property="og:image" content="https://example.com/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_512x512_fill_lanczos_center_3.png" />
    <meta property="twitter:image" content="https://example.com/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_512x512_fill_lanczos_center_3.png" /><meta property="og:locale" content="en-us" />
  
    
      <meta property="og:updated_time" content="2023-01-24T00:00:00&#43;00:00" />
    
  

  



  


  <title>Cancers | BM Sci-Tech Memento</title>

  
  
  
  











</head>


<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="page-wrapper   "  >

  
  
  
  
  
  
  
  
  
  <script src="/js/wowchemy-init.min.613040fe4f2c0f007b4dcb64404201cb.js"></script>

  


<aside class="search-modal" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#" aria-label="Close"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search" class="form-control"
        aria-label="Search...">
        
      </div>

      
      

      

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>



  <div class="page-header">
    












<header class="header--fixed">
  <nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
    <div class="container-xl">

      
      <div class="d-none d-lg-inline-flex">
        <a class="navbar-brand" href="/">BM Sci-Tech Memento</a>
      </div>
      

      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar-content" aria-controls="navbar-content" aria-expanded="false" aria-label="Toggle navigation">
      <span><i class="fas fa-bars"></i></span>
      </button>
      

      
      <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
        <a class="navbar-brand" href="/">BM Sci-Tech Memento</a>
      </div>
      

      
      
      <div class="navbar-collapse main-menu-item collapse justify-content-end" id="navbar-content">

        
        <ul class="navbar-nav d-md-inline-flex">
          

          

          
          
          

          

          
          
          
          

          
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/"><span>Home</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/tool/"><span>Tools</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/docs/"><span>Notes</span></a>
          </li>

          
          

          

          
          
          
            
              
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="https://pubmed.ncbi.nlm.nih.gov/" target="_blank" rel="noopener"><span>PubMed</span></a>
          </li>

          
          

          

          
          
          
            
              
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="https://licore.netlify.app/" target="_blank" rel="noopener"><span>MII</span></a>
          </li>

          
          

        

          
        </ul>
      </div>

      <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">

        
        

        
        
        <li class="nav-item">
          <a class="nav-link js-search" href="#" aria-label="Search"><i class="fas fa-search" aria-hidden="true"></i></a>
        </li>
        

        
        
        
        <li class="nav-item dropdown theme-dropdown">
          <a href="#" class="nav-link" data-toggle="dropdown" aria-haspopup="true" aria-label="Display preferences">
            <i class="fas fa-moon" aria-hidden="true"></i>
          </a>
          <div class="dropdown-menu">
            <a href="#" class="dropdown-item js-set-theme-light">
              <span>Light</span>
            </a>
            <a href="#" class="dropdown-item js-set-theme-dark">
              <span>Dark</span>
            </a>
            <a href="#" class="dropdown-item js-set-theme-auto">
              <span>Automatic</span>
            </a>
          </div>
        </li>
        

        
        

      </ul>

    </div>
  </nav>
</header>


  </div>

  <div class="page-body">
    
    
    

    












  

  
  
  
    
  
<div class="universal-wrapper pt-3">
  <h1>Cancers</h1>

  

  
</div>



<div class="universal-wrapper">
  

  
  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36309200/" >DCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis</a>
    </div>

    
    <a href="/article/36309200/"  class="summary-link">
      <div class="article-style">
        Abstract
Background &amp; Aims
Gastrointestinal cancer stem cell marker doublecortin-like kinase (DCLK1) is strongly associated with poor outcomes in colorectal cancer (CRC). Although DCLK1’s regulatory effect on the tumor immune microenvironment has been hypothesized, its mode of action has not been shown previously in vivo, which hampers the potential intervention based on this molecule for clinical practice.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Wednesday, 26 October 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.cmghjournal.org/article/S2352-345X%2822%2900224-7/fulltext" target="_blank" rel="noopener">
    Cellular and Molecular Gastroenterology and Hepatology</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36309200/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791173/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36309200/" >
      <img src="/article/36309200/featured_huc1ff65294624eed8483c0fa423428042_38713_150x0_resize_q75_h2_lanczos.webp" height="59" width="150"
           alt="DCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36283801/" >Targeting tumour-intrinsic N7-methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy</a>
    </div>

    
    <a href="/article/36283801/"  class="summary-link">
      <div class="article-style">
        Abstract
Objective Intrahepatic cholangiocarcinoma (ICC) exhibits very low response rate to immune checkpoint inhibitors (ICIs) and the underlying mechanism is largely unknown. We investigate the tumour immune microenvironment (TIME) of ICCs and the underlying regulatory mechanisms with the aim of developing new target to inhibit tumour growth and improve anti-programmed cell death protein-1 (PD-1) efficacy.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Tuesday, 25 October 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://gut.bmj.com/content/early/2022/10/25/gutjnl-2022-327230.long" target="_blank" rel="noopener">
    Gut</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36283801/" target="_blank" rel="noopener">
    PubMed</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36283801/" >
      <img src="/article/36283801/featured_hu93c5900b1cafb8845e366f2001cc6842_228214_150x0_resize_q75_h2_lanczos.webp" height="174" width="150"
           alt="Targeting tumour-intrinsic N7-methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36280710/" >Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity</a>
    </div>

    
    <a href="/article/36280710/"  class="summary-link">
      <div class="article-style">
        Abstract
STING, an endoplasmic reticulum (ER) transmembrane protein, mediates innate immune activation upon cGAMP stimulation and is degraded through autophagy. Here, we report that activated STING could be transferred between cells to promote antitumor immunity, a process triggered by RAB22A-mediated non-canonical autophagy.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Monday, 24 October 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.nature.com/articles/s41422-022-00731-w" target="_blank" rel="noopener">
    Cell Research</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36280710/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715632/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36280710/" >
      <img src="/article/36280710/featured_hue9557da542f15c989213454443e76923_158910_150x0_resize_q75_h2_lanczos.webp" height="85" width="150"
           alt="Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/review/36283584/" >Circular RNAs: Emerging regulators of glucose metabolism in cancer</a>
    </div>

    
    <a href="/review/36283584/"  class="summary-link">
      <div class="article-style">
        Abstract
Aberrant glucose metabolism is one of the most striking characteristics of metabolic reprogramming in cancer. Thus, clarifying the regulatory mechanism of glucose metabolism is crucial to understanding tumor progression and developing novel therapeutic strategies for cancer patients.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Saturday, 22 October 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.sciencedirect.com/science/article/pii/S0304383522004657" target="_blank" rel="noopener">
    Cancer Letters</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36283584/" target="_blank" rel="noopener">
    PubMed</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/review/36283584/" >
      <img src="/review/36283584/featured_hu6841748a632ddcb1335d0e8a54f140a0_550762_150x0_resize_q75_h2_lanczos.webp" height="77" width="150"
           alt="Circular RNAs: Emerging regulators of glucose metabolism in cancer" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36271053/" >Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12</a>
    </div>

    
    <a href="/article/36271053/"  class="summary-link">
      <div class="article-style">
        Abstract
Dysregulated expression of splicing factors has important roles in cancer development and progression. However, it remains a challenge to identify the cancer-specific splicing variants. Here we demonstrate that spliceosome component BUD31 is increased in ovarian cancer, and its higher expression predicts worse prognosis.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Friday, 21 October 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.nature.com/articles/s41467-022-34042-w" target="_blank" rel="noopener">
    Nature Communications</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36271053/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587234/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36271053/" >
      <img src="/article/36271053/featured_hu64b0eb608f999b6f2880b94497bdf063_479570_150x0_resize_q75_h2_lanczos.webp" height="179" width="150"
           alt="Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36252997/" >Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization</a>
    </div>

    
    <a href="/article/36252997/"  class="summary-link">
      <div class="article-style">
        Abstract
Background: Despite the success of HER2-targeted therapy in achieving prolonged survival in approximately 50% of treated individuals, treatment resistance is still an important challenge for HER2+ breast cancer (BC) patients.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Monday, 17 October 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://jitc.bmj.com/content/10/10/e004666" target="_blank" rel="noopener">
    The Journal for ImmunoTherapy of Cancer</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36252997/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577936/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36252997/" >
      <img src="/article/36252997/featured_hucbe6238d3a2c7b2e19c5d4af4a15f990_112124_150x0_resize_q75_h2_lanczos.webp" height="102" width="150"
           alt="Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36241718/" >A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers</a>
    </div>

    
    <a href="/article/36241718/"  class="summary-link">
      <div class="article-style">
        Abstract
Mutations of the RAS oncogene are found in around 30% of all human cancers yet direct targeting of RAS is still considered clinically impractical except for the KRASG12C mutant. Here we report that RAS-ON (RASON), a novel protein encoded by the long intergenic non-protein coding RNA 00673 (LINC00673), is a positive regulator of oncogenic RAS signaling.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Friday, 14 October 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.nature.com/articles/s41422-022-00726-7" target="_blank" rel="noopener">
    Cell Research</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36241718/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810732/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36241718/" >
      <img src="/article/36241718/featured_hu1860ad4ff539ea01155a979aec820ee6_5412_150x0_resize_q75_h2_lanczos.webp" height="150" width="150"
           alt="A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36224181/" >Targeting EGFR-dependent tumors by disrupting an ARF6-mediated sorting system</a>
    </div>

    
    <a href="/article/36224181/"  class="summary-link">
      <div class="article-style">
        Abstract
Aberrant activation of EGFR due to overexpression or mutation is associated with poor prognosis in many types of tumors. Here we show that blocking the sorting system that directs EGFR to plasma membrane is a potent strategy to treat EGFR-dependent tumors.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Wednesday, 12 October 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.nature.com/articles/s41467-022-33788-7" target="_blank" rel="noopener">
    Nature Communications</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36224181/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556547/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36224181/" >
      <img src="/article/36224181/featured_hu67226f93c9054105e1b01758b467ed37_81848_150x0_resize_q75_h2_lanczos.webp" height="146" width="150"
           alt="Targeting EGFR-dependent tumors by disrupting an ARF6-mediated sorting system" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36224588/" >Two circPPFIA1s negatively regulate liver metastasis of colon cancer via miR-155-5p/CDX1 and HuR/RAB36</a>
    </div>

    
    <a href="/article/36224588/"  class="summary-link">
      <div class="article-style">
        Abstract
Background: Circular RNAs (circRNAs) play a critical role in colorectal cancer (CRC) progression, including metastasis. However, the detailed molecular mechanism is not fully understood.
Methods: Differentially expressed circRNAs between primary KM12C and liver metastatic KM12L4 colon cancer cells were identified by microarray.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Wednesday, 12 October 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-022-01667-w" target="_blank" rel="noopener">
    Molecular Cancer</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36224588/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555114/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36224588/" >
      <img src="/article/36224588/featured_hu087bd44843fca61ba782ba7ea5e12622_75656_150x0_resize_q75_h2_lanczos.webp" height="88" width="150"
           alt="Two circPPFIA1s negatively regulate liver metastasis of colon cancer via miR-155-5p/CDX1 and HuR/RAB36" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36214223/" >Integrated T cell cytometry metrics for immune-monitoring applications in immunotherapy clinical trials</a>
    </div>

    
    <a href="/article/36214223/"  class="summary-link">
      <div class="article-style">
        Abstract
Mass cytometry, or cytometry by TOF (CyTOF), provides a robust means of determining protein-level measurements of more than 40 markers simultaneously. While the functional states of immune cells occur along continuous phenotypic transitions, cytometric studies surveying cell phenotypes often rely on static metrics, such as discrete cell-type abundances, based on canonical markers and/or restrictive gating strategies.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Monday, 10 October 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://insight.jci.org/articles/view/160398" target="_blank" rel="noopener">
    JCI Insight</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36214223/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675468/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36214223/" >
      <img src="/article/36214223/featured_hub256454ca71d33c8cab2ec0e9a31cd89_106954_150x0_resize_q75_h2_lanczos.webp" height="162" width="150"
           alt="Integrated T cell cytometry metrics for immune-monitoring applications in immunotherapy clinical trials" loading="lazy">
    </a>
    
  </div>
</div>

  

  
<nav class="mt-1">
  <ul class="pagination justify-content-center">
    
    <li class="page-item"><a class="page-link" href="/tag/cancers/page/10/">&laquo;</a></li>
    
    
    <li class="page-item"><a class="page-link" href="/tag/cancers/page/12/">&raquo;</a></li>
    
  </ul>
</nav>


</div>
  </div>

  <div class="page-footer">
    
    
    <div class="container">
      <footer class="site-footer">

  












  

  

  

  
  






  
  <p class="powered-by copyright-license-text">
    Copyright © 2023 | Biomedist | All rights reserved.
  </p>
  




  <p class="powered-by">
    
    
    
      
      
      
      
      
      
      Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target="_blank" rel="noopener">Wowchemy</a> — the free, <a href="https://github.com/wowchemy/wowchemy-hugo-themes" target="_blank" rel="noopener">open source</a> website builder that empowers creators.
    
  </p>
</footer>

    </div>
    
  </div>

  


<script src="/js/vendor-bundle.min.d26509351aa0ff874abbee824e982e9b.js"></script>




  

  
  

  













  
  <script id="search-hit-fuse-template" type="text/x-template">
    <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
    </div>
  </script>
  
    <script src="https://cdn.jsdelivr.net/gh/krisk/Fuse@v3.2.1/dist/fuse.min.js" integrity="sha512-o38bmzBGX+hD3JHWUFCDA09btWaqrNmoJ3RXLlrysA7PP01Kgs4UlE4MhelE1v5dJR3+cxlR4qQlotsW7jKsnw==" crossorigin="anonymous"></script>
    <script src="https://cdn.jsdelivr.net/gh/julmot/mark.js@8.11.1/dist/jquery.mark.min.js" integrity="sha512-mhbv5DqBMgrWL+32MmsDOt/OAvqr/cHimk6B8y/bx/xS88MVkYGPiVv2ixKVrkywF2qHplNRUvFsAHUdxZ3Krg==" crossorigin="anonymous"></script>
  












  
  
  
  
  
  
  







<script id="page-data" type="application/json">{"use_headroom":true}</script>



  <script src="/js/wowchemy-headroom.c251366b4128fd5e6b046d4c97a62a51.js" type="module"></script>








  
  


<script src="/en/js/wowchemy.min.54dd6e4d8f2e4b1d098381b57f18dd83.js"></script>























</body>
</html>
